Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer.
Rugo H, Shtivelman E, Perez A, Vogel C, Franco S, Tan Chiu E, Melisko M, Tagliaferri M, Cohen I, Shoemaker M, Tran Z, Tripathy D.
Rugo H, et al. Among authors: tagliaferri m.
Breast Cancer Res Treat. 2007 Sep;105(1):17-28. doi: 10.1007/s10549-006-9430-6. Epub 2006 Nov 17.
Breast Cancer Res Treat. 2007.
PMID: 17111207
Clinical Trial.